SCHEMBL19632076

SCHEMBL19632076

CC(=O)c1ccc2nc(C(=O)C(C)C)cn2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
RAB9A P51151 8/20 0.37
MAPT P10636 5/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
KDM4E B2RXH2 8/20 0.37
NPC1 O15118 7/20 0.37
GAA P10253 3/20 0.37
MAPK1 P28482 2/20 0.37
DBH P09172 1/20 0.37
RECQL P46063 1/20 0.37
STAT3 P40763 1/20 0.37
STAT1 P42224 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ALDH1A1 P00352 5/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
HSP90AA1 P07900 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
EGLN1 Q9GZT9 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15223780 0.85 HRH4 (0.41) HRH4HRH3RAB9AMAPTSMN1; SMN2
SCHEMBL22147857 0.83 PTGS1 (0.54) HRH4HRH3RAB9AMAPTSMN1; SMN2
SCHEMBL20646876 0.80 HRH4 (0.57) HRH4HRH3RAB9AMAPTSMN1; SMN2
SCHEMBL1500335 0.80 PIK3CG (0.47) HRH4HRH3RAB9ASMN1; SMN2KDM4E
SCHEMBL19632006 0.79 RAB9A (0.42) HRH4HRH3RAB9AMAPTSMN1; SMN2
SCHEMBL15222278 0.79 MAP3K5 (0.39) HRH4HRH3RAB9AMAPTSMN1; SMN2
SCHEMBL2087833 0.78 PTGS1 (0.45) RAB9AMAPTSMN1; SMN2KDM4ENPC1
SCHEMBL19400570 0.77 POLB (0.48) RAB9AMAPTSMN1; SMN2NPC1TDP1
SCHEMBL20646999 0.77 APP (0.48) HRH4HRH3RAB9ASMN1; SMN2KDM4E
SCHEMBL19632159 0.77 KDM4E (0.46) HRH4HRH3RAB9AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180147289-A9 Novel Conjugates of CC-1065 Analogs and Bifunctional Linkers SYNTARGA BV (NL) 2018-05-31 US disclosed
US-20170333567-A1 Novel Conjugates of CC-1065 Analogs and Bifunctional Linkers SYNTARGA BV (NL) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170333567-A1 Novel Conjugates of CC-1065 Analogs and Bifunctional Linkers PCNA, DCLRE1A, CDC5L HRH4 2715/4885HRH3 1777/4885RAB9A 4266/4885
US-20180147289-A9 Novel Conjugates of CC-1065 Analogs and Bifunctional Linkers PCNA, DCLRE1A, CDC5L HRH4 2715/4885HRH3 1777/4885RAB9A 4266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.